Cutaneous Lymphoma Associated With Epstein-Barr Virus Infection in 2 Patients Treated With Methotrexate
Anne Tournadre(Université Clermont Auvergne), Martin Soubrier(Centre Hospitalier Universitaire de Clermont-Ferrand), F. Franck(Hôtel-Dieu de Lyon), Pierre Déchelotte(Inserm), P Souteyrand(Centre Hospitalier Universitaire de Clermont-Ferrand), Jean‐Jacques Dubost(Centre Hospitalier Universitaire de Clermont-Ferrand), M. D’Incan(Centre Hospitalier Universitaire de Clermont-Ferrand)
Cited by 45
Related Papers
Prevalence of eating disorders over the 2000–2018 period: a systematic literature review
|American Journal of Clinical Nutrition|2018|1.7k
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis
|Arthritis & Rheumatism|2002|574
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501